Thus, it seems that the inhibition of NLRP3 inflammasome activation and effects may point towards a better understanding of the molecular mechanism that can be further explored in post-ischemic stroke (with or without COVID-19) brain repair. The gene discussed is NLRP3; the disease is COVID-19.